Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
D NIB 50mg Injection
Manufacturer/Marketed By : BDR PHARMACEUTICALS INT PVT LTD
$35.57 $24.96
D nib 50mg injection contains the active substance decitabine. It is an antineoplastic drug that belongs to the class of medications called DNA methylation inhibitors. It is used to treat...
DECITABINE
Active Pharmaceutical Ingredient
D NIB 50mg Injection
$35.57
$24.96
D nib 50mg injection contains the active substance decitabine. It is an antineoplastic drug that belongs to the class of medications called DNA methylation inhibitors. It is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and do not produce enough healthy blood cells). It is also used to treat a type of cancer called acute myeloid leukemia (AML). It works by stopping the cancer cells from growing. Do not take this injection if you are allergic to decitabine or any other ingredients of this medicine. Inform your physician if you have an infection, decreased blood cell count, liver disease, kidney disorder, and a heart disorder. This medicine is not recommended for children or young people below 18 years of age. This medicine can cause a serious immune reaction called differentiation syndrome. Report to your physician if you face any symptoms of sudden difficulty in breathing, cough, fever, or swelling in the body. D nib 50mg injection should not be used in pregnant and breastfeeding women. Inform your physician if you are pregnant or breastfeeding. Use effective contraception throughout the therapy to avoid pregnancy. The common adverse reactions are decreased white blood cells, red blood cells, platelet counts, and increased body temperature.
Active Pharmaceutical Ingredient
Uses
• Myelodysplastic syndromes (MDS)
• Acute myeloid leukemia (AML)
Benefits
D nib 50mg injection promotes hypomethylation of DNA and cellular differentiation or cell death after phosphorylation, direct incorporation into DNA, and inhibition of DNA methyltransferase. It works by helping the bone marrow produce normal blood cells and by killing abnormal cells in the bone marrow.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Heart problems
• Anemia
• Infection
• Bleeding
• Fluid in the lungs
• Pneumonia
Common Side Effects
• Swelling in the face, hands, and feet
• Swelling and pain in the skin
• Discoloration of the skin
• Increased blood sugar levels
• Decreased albumin levels
• Abdominal pain, constipation
• Decrease in appetite
• Diarrhea, indigestion
• Nausea, vomiting
• Insomina, dizziness
• Pain in limbs
How To Use
It will be given to you by a doctor or nurse in a hospital or clinic setting trained in cancer chemotherapy. It is given as an intravenous infusion drip (into your vein). This will take one hour. Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity, body weight, and other factors.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended in patients taking D nib 50mg injection because the medicine passes into the breast milk in small amounts and may harm your baby.
• Alcohol: It is unknown whether consuming alcohol is safe during the treatment with D nib 50mg injection. Inform your doctor if you are a chronic drinker.
• Liver: It is unknown whether D nib 50mg injection can be used in patients with liver disorders. Consult your doctor if you have any liver problems before starting the treatment.
• Lungs: It is unknown whether D nib 50mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: D nib 50mg injection may make you feel tired, dizzy, or sleepy. It is unsafe to drive or operate heavy machinery after taking this medicine.
• Pregnancy: D nib 50mg injection is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 6 months after your last dose is necessary.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.



